|
Session 16-Themed Discussion
TD: Hepatitis B and C: The Next Chapter in the Management of HIV in Resource-limited Countries
Wednesday, 1-2 pm; Room 2005 |
689
 |
High Prevalence of Unexplained Liver Fibrosis Associated with HIV in Rural Southwestern Uganda
Larissa Stabinskil1, S Reynolds1, P Ocama2, K Newell3, A Ndyanabo4, D Thomas5, R Gray5, M Wawer5, T Quinn1, and G Kirk5
1NIH, Bethesda, MD, US; 2Makerere Univ, Kampala, Uganda; 3SAIC Inc, Rakai, Uganda; 4Rakai Hlth Sci Prgm, Uganda; and 5Johns Hopkins Univ, Baltimore, MD, US |
| 690 |
Response to ART in HBV/HIV Co-infected West Africans
David Chadwick1, F Sarfo2, M Ankcorn1, M Patel3, A Garcia3,4, A M Geretti3,4, and R Phillips2,5
1The James Cook Univ Hosp, Middlesbrough, UK; 2Komfo Anokye Teaching Hosp, Kumasi, Ghana; 3Royal Free Hampstead NHS Trust, London, UK; 4Univ Coll London Med Sch, UK; and 5Kwame Nkrumah Univ of Sci and Tech, Kumasi, Ghana |
691
|
Factors Associated with Hepatotoxicity in an International HIV/HBV Co-infected Cohort on Long-term HAART
Jennifer Audsley1,2, E Seaberg3, J Sasadeusz2, G Matthews4, A Avihingsanon5, K Ruxrungtham5, G Dore4, S Locarnini6, C Thio3, and S Lewin1,2
1Monash Univ, Melbourne, Australia; 2The Alfred Hosp, Melbourne, Australia; 3Johns Hopkins Univ Sch of Med, Baltimore, MD, US; 4Natl Ctr in HIV Epi and Clin Res, Sydney, Australia; 5HIVNAT Res Collaboration, Bangkok, Thailand; and 6Victorian Infectious Diseases Reference Lab, Melbourne, Australia |
692
|
Characterization of HBV and Its Association with HIV in an ART-naïve, Multi-national Cohort from 2 Randomized Controlled Trials of the AIDS Clinical Trials Group
Chloe Thio1, L Smeaton2, M Saulynas1, H Hwang1, N Kumarasamy3, T Flanigan4, J Hakim5, F Amod6, T Campbell7, J Currier8, and PEARLS/A5175 and OCTANE/A5208 Study Teams for the ACTG
1Johns Hopkins Univ, Baltimore, MD, US; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3YR Gaitonde Ctr for AIDS Res and Ed, Chennai, India; 4Warren Alpert Med Sch of Brown Univ, Providence, RI, US; 5Univ of Zimbabwe Coll of Hlth Sci, Harare; 6Nelson Mandela Sch of Med, Univ of KwaZulu-Natal, Durban, South Africa; 7Univ of Colorado Hlth Sci Ctr, Denver, US; and 8Univ of California, Los Angeles, US |
693
|
Prevalence of HCV Infection among HIV-1-infected Pregnant Women in Malawi: The BAN Study
Charles Chasela1,2 and the BAN Study Team
1UNC Project, Lilongwe, Malawi and 2Univ Coll Dublin, Ireland |
| 694 |
Prevalence of Hepatitis B and C Co-infection and Response to ART among HIV-infected Patients in an Urban Setting in Tanzania
B Christian1, J Okuma2, Claudia Hawkins1,3, G Chalamilla1,2, D Spiegelman2, T Nagu4, M Kanyangarara1, F Mugusi4, and W Fawzi1,2
1MDH HIV/AIDS Care and Treatment Prgm, Dar es Salaam, Tanzania; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Northwestern Univ, Chicago, IL, US; and 4Muhimbili Univ of Hlth and Allied Sci, Dar es Salaam, Tanzania |
| 695 |
Prevalence and Clinical Course of Occult HBV Infection in Serology Negative HIV Patients in Johannesburg, South Africa
Cynthia Firnhaber1, C Yu Chen1, D Evans1, M Maskew1, D Schulze1, A Reyneke1, A Di Bisceglie2, and A Kramvis1
1Univ of the Witwatersrand, Johannesburg, South Africa and 2St Louis Univ, MO, US |
| 696 |
HBV Polymerase and Surface Mutations in a Cohort of HIV/HBV Co-infected Patients Accessing Lamivudine-based HAART in Kumasi, Ghana
A Garcia-Diaz1,2, D Chadwick3, M Patel2, R Phillips4, and Anna Maria Geretti1,2
1Univ Coll London Med Sch, UK; 2Royal Free Hampstead NHS Trust, London, UK; 3The James Cook Univ Hosp, Middlesbrough, UK; and 4Kwame Nkrumah Univ of Sci and Tech, Kumasi, Ghana |
|
